tybost
gilead sciences ireland uc - kobicistats - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
regaine 20 mg/ml uz ādas lietojams šķīdums
mcneil healthcare (ireland) limited, ireland - minoksidils - uz ādas lietojams šķīdums - 20 mg/ml
regaine 50 mg/ml uz ādas lietojams šķīdums
mcneil healthcare (ireland) limited, ireland - minoksidils - uz ādas lietojams šķīdums - 50 mg/ml
fucicort 20 mg/1 mg/g krēms
leo pharma a/s, denmark - skābes fusidicum, betamethasoni valeras - krēms - 20 mg/1 mg/g
fucicort 20 mg/1 mg/g krēms
leo pharma a/s, denmark - skābes fusidicum, betamethasoni valeras - krēms - 20 mg/1 mg/g
dexamethason krka 40 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 40 mg
dexamethason krka 20 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 20 mg
dexamethason krka 4 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 4 mg
dexamethason krka 8 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 8 mg
dexamethasone krka 20 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 20 mg